Literature DB >> 23307189

Histology and immunohistochemistry of clear cell adenocarcinoma of the urethra: histogenesis and diagnostic problems.

Borislav A Alexiev1, Fabio Tavora.   

Abstract

Clear cell adenocarcinoma (CCAC) of the urethra is a rare neoplasm, morphologically identical to its homologue arising in the female genital tract. The histogenesis of this neoplasm is uncertain. We present clinical, histopathologic, and immunohistochemical findings of four CCAC of the urethra and discuss the histogenesis and difficulties in diagnosis and differential diagnosis. CCAC of the urethra occurred in females (4/4). Two neoplasms were identified in urethral diverticulum; one of the two cases, in close proximity to a nephrogenic adenoma. CCAC exhibited tubulocystic, papillary, and diffuse/solid growth patterns. The neoplastic cells were cuboidal or columnar with eosinophilic or clear cytoplasm, and nuclear pleomorphism of at least moderate degree. Hobnail features and tumor necrosis were also observed. CCAC expressed p53 (4/4), AMACR (3/4), vimentin (3/4), PAX8 (2/4), CK7 (2/4), cytokeratin 34betaE12 (2/4), RCC (1/4), and CK20 (1/4) and were negative for PSA, WT1, ER, CA 125, uroplakin III, p16, and p63. The immunohistochemical profile supports a possible renal tubular cell differentiation/mesonephric origin for some urethral CCAC. Nephrogenic adenoma and metastatic clear cell carcinoma are the most important differential diagnostic considerations. Multicenter studies on more cases may improve our understanding of this malignancy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23307189     DOI: 10.1007/s00428-012-1363-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  30 in total

Review 1.  Primary carcinomas of the urethra.

Authors:  M B Amin; R H Young
Journal:  Semin Diagn Pathol       Date:  1997-05       Impact factor: 3.464

2.  Incidence of primary urethral carcinoma in the United States.

Authors:  Mia A Swartz; Michael P Porter; Daniel W Lin; Noel S Weiss
Journal:  Urology       Date:  2006-12-04       Impact factor: 2.649

3.  Mesonephroid adenocarcinoma arising from mesonephroid metaplasia of the urinary bladder.

Authors:  Henrik Suttmann; Konstanze Holl-Ulrich; Melanie Peter; Ingo Kausch; Christian Doehn; Dieter Jocham
Journal:  Urology       Date:  2006-03-29       Impact factor: 2.649

Review 4.  Clear cell adenocarcinoma of the urinary bladder.

Authors:  Mustafa Kösem; Erdal Sengül
Journal:  Scand J Urol Nephrol       Date:  2005

5.  Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin.

Authors:  Ming-Tse Sung; Shaobo Zhang; Gregory T MacLennan; Antonio Lopez-Beltran; Rodolfo Montironi; Mingsheng Wang; Puay-Hoon Tan; Liang Cheng
Journal:  Clin Cancer Res       Date:  2008-04-01       Impact factor: 12.531

6.  Glycogen-rich clear cell carcinoma of the urethra: an ultrastructural study.

Authors:  M T Hull; D E Eglen; T Davis; M D Glant; J N Eble
Journal:  Ultrastruct Pathol       Date:  1987       Impact factor: 1.094

7.  Clear cell adenocarcinoma of the bladder and urethra: cases diffusely mimicking nephrogenic adenoma.

Authors:  Mehsati Herawi; Peter A Drew; Chin-Chen Pan; Jonathan I Epstein
Journal:  Hum Pathol       Date:  2010-01-08       Impact factor: 3.466

8.  Primary mesonephric carcinoma of the female urethra.

Authors:  D J Rivard; S S Waisman
Journal:  J Urol       Date:  1985-10       Impact factor: 7.450

9.  Adenocarcinoma of the male urethra with associated nephrogenic metaplasia. Case report and review of the literature.

Authors:  E A Ingram; P DePauw
Journal:  Cancer       Date:  1985-01-01       Impact factor: 6.860

10.  Adenocarcinoma of the female urethra: Clear-cell variant.

Authors:  Jordan Caplan; Matthew Hartman; Gina Rooker
Journal:  Radiol Case Rep       Date:  2015-11-06
View more
  4 in total

1.  Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas.

Authors:  Oluwole Fadare; Vinita Parkash; Katja Gwin; Krisztina Z Hanley; Elke A Jarboe; Sharon X Liang; Charles M Quick; Wenxin Zheng; Kojo R Rawish; Jonathan L Hecht; Mohamed M Desouki
Journal:  Hum Pathol       Date:  2013-10-10       Impact factor: 3.466

2.  Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing.

Authors:  Rohit Mehra; Pankaj Vats; Shanker Kalyana-Sundaram; Aaron M Udager; Michael Roh; Ajjai Alva; Jincheng Pan; Robert J Lonigro; Javed Siddiqui; Alon Weizer; Cheryl Lee; Xuhong Cao; Yi-Mi Wu; Dan R Robinson; Saravana M Dhanasekaran; Arul M Chinnaiyan
Journal:  Am J Pathol       Date:  2014-01-03       Impact factor: 4.307

3.  Dataset for the reporting of carcinoma of the bladder-cystectomy, cystoprostatectomy and diverticulectomy specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Authors:  E Compérat; J R Srigley; F Brimo; B Delahunt; M Koch; A Lopez-Beltran; V Reuter; H Samaratunga; J H Shanks; T Tsuzuki; T van der Kwast; M Varma; F Webster; D Grignon
Journal:  Virchows Arch       Date:  2020-01-08       Impact factor: 4.064

4.  Unusual Features of Clear Cell Adenocarcinoma of the Female Urethra: A Case Report and Literature Review.

Authors:  Jianfeng Zeng; Shanyun Wang; Liang Zhong; Zhifeng Huang; Ye Zeng; Song Wu; Dongxiang Zheng; Weiwei Zou; Haibiao Lai
Journal:  J Clin Med Res       Date:  2018-06-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.